Skip to main content
. 2025 Dec 19;6(3):314–325. doi: 10.1016/j.jacasi.2025.09.027

Table 3.

Restricted Mean Survival Time Analysis for Bleeding and All-Cause Death

Outcome Comparison Groupa ΔRMST (d) 95% CI RMST Cardiac RMST Noncardiac RMST Exogenous
Any bleeding Noncardiac −0.25 −3.04 to 2.06 22.74 22.49 24.66
Exogenous 1.91 −0.34 to 4.23 22.74 22.49 24.66
Procedure-related bleeding Noncardiac −0.08 −2.46 to 1.87 23.70 23.62 24.68
Exogenous 0.98 −1.25 to 3.21 23.70 23.62 24.68
Nonprocedure-related bleeding Noncardiac −1.41 −3.47 to 0.31 26.70 25.28 27.66
Exogenous 0.96 0.34-1.62 26.70 25.28 27.66
All-cause death Noncardiac −0.19 −1.97 to 1.42 8.05 7.86 8.11
Exogenous 0.06 −1.87 to 2.17 8.05 7.86 8.11
Comparison Groupb ΔRMST (d) 95% CI RMST IABP Use RMST No IABP
Any bleeding IABP use −2.69 −4.29 to −1.11 20.89 23.58
Procedure-related bleeding IABP use −2.13 −3.53 to −0.66 22.40 24.54
Nonprocedure-related bleeding IABP use −1.74 −2.71 to −0.82 25.26 26.99
All-cause death IABP use 5.58 4.26-6.77 12.63 7.04
a

Reference, cardiac stratum.

b

Reference, no intra-aortic balloon pumping (IABP) group. ΔRestricted mean survival time (RMST) = RMST (Comparison) – RMST (Reference). Positive values indicate longer mean event-free survival in the comparison group.